SecBot SecBot
SECBOTREPLAY Home › Report › LFWD

LFWD · Lifeward Ltd

Lifeward Ltd. · 8-K filed May 19, 2026 at 08:37 ET

At the news

NEUTRALIMPACT 2/10

8-K filed May 19, 2026 at 08:37 ET

Lifeward Ltd. announced the appointment of Dr. Keith D. Rose, an internal promotion from VP Medical Affairs to Chief Medical Officer, effective May 1, 2026. This is a routine executive personnel change within a small-cap medtech company with no material financial or operational impact disclosed.

  • Appointment of Keith D. Rose, M.D. as Chief Medical Officer effective May 1, 2026
  • Dr. Rose has been with Lifeward since March 2023, most recently serving as VP Medical Affairs, Medical Director Neurosciences
  • No financial terms, compensation details, or operational changes were disclosed in the filing
  • Company market cap is approximately $18M with 88% analyst bullish consensus

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access